We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Aggrenox End-Payors Want $18M Atty Fees In $54M Deal

Law360 (April 13, 2018, 8:20 PM EDT) -- Indirect buyers of Aggrenox told a Connecticut federal judge Friday that attorneys who represented the putative class alleging that Teva Pharmaceutical and Boehringer Ingelheim blocked generic alternatives to the stroke-prevention drug from coming to the market should get $18 million of the proposed $54 million settlement.

The putative class said the firms Miller Law LLC, Heins Mills & Olson PLC and Hilliard & Shadowen LLP should take a third of the settlement because the litigation was complex, involved nearly 41,000 hours of work and was risky...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.